Niki BioSolutions, Inc. Unrealized Gain (Loss) on Derivatives
Niki BioSolutions, Inc. (NIKI) reported Unrealized Gain (Loss) on Derivatives of $87.60 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2020-04-29
| Period end | Unrealized Gain (Loss) on Derivatives 10 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|
| 2019-12-31 | $87.60K 20-F · filed 2020-04-29 | |
| 2018-12-31 | -$974.44K 20-F · filed 2020-04-29 | |
| 2017-12-31 | -$827.50K 20-F · filed 2020-04-29 |